| Ilevro (U.S.N.L.M.) | |
|---|---|
| Dosing | 1 drop daily beginning 1 day before cataract surgery, the day of surgery, an additional drop 30 to 120 minutes prior to surgery and continue for 2 weeks. |
| Chem Specs | nepafenac suspension 0.3% |
| Quantities | 1.7ml, 3ml |
| Cost | 372.55 / 1.7ml |
| Class | Prodrug of amfenac a COX inhibitor NSAID |
| Action | Inhibits prostaglandin synthesis. |
| Usage | Indicated for the treatment of inflammation and reduction of ocular pain post cataract surgery. |
| Warnings include increased bleeding time, delayed healing, and keratitis. | |
| Contraindications | Hypersensitivity to any ingredient in the formulation or to other NSAIDS. |
| Pediatric use | Safety and efficacy in patients below the age of 10 not established. |
| Pregnancy | Prostaglandin biosynthesis inhibitors harm the fetal cardiovascular system. |
| 5 to 10% adverse reactions include capsular opacity, foreign body sensation, increased IOP. 0.005% BAK. |